Widely Cited Prostate-specific Antigen Screening Publications Influence...
ROCHESTER, Minn. — While absolute rates of biopsy and post-biopsy complications have decreased following several benchmark prostate-specific antigen (PSA) screening publications, the relative risk for...
View ArticleShorter, Intensive Radiation Can Be Recommended in Early Prostate Cancer
By Duke Medicine News and Communications
View ArticleNew research suggests early life factors could increase prostate cancer risk
Factors that influence when boys go through puberty could affect a man’s future risk of developing prostate cancer, a large study funded by World Cancer Research Fund has found.
View ArticleMen could be spared unnecessary treatment for prostate cancer with new...
Researchers are working to find a way to determine how serious prostate cancer is when first diagnosed to avoid unnecessary treatments, which can cause life long side effects and even death.
View ArticleCommon prostate cancer treatments suppress immune response and may promote...
DALLAS – Prostate cancer patients and their doctors may want to think twice about the best timing for chemotherapy or radiation therapy in conjunction with a common nonsurgical treatment, based on...
View ArticleHormone Therapy for Prostate Cancer May Increase Risk of Depression
A new study led by researchers at Brigham and Women's Hospital (BWH) has found a significant association between depression and patients being treated for localized prostate cancer (PCa) by androgen...
View ArticlePotential Cholesterol-Lowering Drug Molecule Has Prostate Cancer Fighting...
COLUMBIA, Mo. – Standard treatment for prostate cancer can include chemotherapy that targets receptors on cancer cells. However, drug-resistant cancer cells can emerge during chemotherapy, limiting its...
View ArticleResearch shows 98% cure rate for prostate cancer using Stereotactic Body...
DALLAS – A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer offers a higher cure rate than more traditional approaches, according to researchers at UT...
View ArticleNew technology quantifies effects of prostate tumor laser ablation
Effort to understand risks of treatment, and prognostic clues to long-term outcomes
View ArticleSanda to lead multi-center prostate cancer biomarker study
The Emory, Harvard, and University of Washington Prostate Cancer Biomarker Center has received a $4.2 million grant from the National Cancer Institute's Early Detection Research Network to develop...
View ArticleNew Model for Active Surveillance of Prostate Cancer Tested
Physician-led quality initiative improves patient care, prevents overtreatment
View ArticleStreamlined approach and treatments improve the quality of care for men with...
The quality of prostate cancer care is improving according to new Monash University research published today in The Medical Journal of Australia.
View ArticleNew England Journal of Medicine Letter to the Editor Calls Prostate Cancer...
NewYork-Presbyterian and Weill Cornell Medicine urologists urge reconsideration of prostate cancer screening after finding critical flaw in landmark study
View ArticleRadiotherapy halves deaths from prostate cancer 15 years after diagnosis
A longitudinal Nordic study, comparing the results of hormone (antiandrogen) therapy with or without the addition of local radiotherapy, shows that a combination of treatments halves the risk of death...
View ArticleNewYork-Presbyterian and Weill Cornell Medicine Doctors Discuss the Future of...
In the May 5 issue of the New England Journal of Medicine, Dr. Jonathan Shoag, a resident in the Department of Urology at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine,...
View ArticleStudy Finds Potential Benefit in Combination Prostate Cancer Immunotherapy
Madison, Wisconsin — A new study from University of Wisconsin Carbone Cancer Center researchers suggests that a combination immunotherapy approach could lead to increased survival for prostate cancer...
View ArticleFDA approves new diagnostic imaging agent to detect recurrent prostate cancer
The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected...
View ArticleFDA approves new diagnostic imaging agent to detect recurrent prostate cancer
The U.S. Food and Drug Administration today approved Axumin, a radioactive diagnostic agent for injection. Axumin is indicated for positron emission tomography (PET) imaging in men with suspected...
View ArticleComputational Method Uncovers New Potential Therapeutic Option for...
The steroid dexamethasone could potentially deter the growth of a prostate cancer subtype that was previously thought to be difficult to treat with medications, Weill Cornell Medicine researchers...
View ArticleScreening Strategy May Predict Lethal Prostate Cancer Later in Life
Prostate cancer screening with prostate-specific antigen (PSA) has been shown to reduce death and the spread of prostate cancer to other parts of the body,
View Article